The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Yi-Jin WuWei Wei

Abstract

The ATP-binding cassette (ABC) transporter family is a large class of ATP energy-dependent transmembrane proteins, and its primary function is to use the energy produced by ATP hydrolysis to transfer the substrate bound to the plasma membrane. This family is also closely related to multidrug resistance (MDR) in various diseases. Among the ABC transporter proteins, P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and breast cancer resistance protein (BCRP) are the main members associated with MDR. At present, the roles of these transporters in therapeutic failures have been extensively studied and reviewed in cancer; however, they have rarely been described in autoimmune diseases (AIDs). AID is a group of chronic inflammatory diseases of unknown aetiology. AID's basic feature is the production of a large number of autoantibodies, which leads to extensive damage to multiple systems and multiple organs. Disease-modifying anti-rheumatic drugs (DMARDs) are commonly used in the treatment of AID, but a considerable number of patients have no response or develop resistance to these drugs over time. This phenomenon may be related to the abnormal expression of the ABC transporter, which leads to a decrease in the amou...Continue Reading

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
Sep 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C Cordon-CardoM R Melamed
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Dec 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P F JurankaV Ling
May 3, 1996·Cell·M FeldmannR N Maini
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Aug 17, 1999·Annual Review of Nutrition·F M Sirotnak, B Tolner
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Apr 5, 2001·Journal of Pharmaceutical Sciences·P M BertilssonK E Magnusson
Aug 17, 2001·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·M SukhaiM Piquette-Miller
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jul 13, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Meguru AchiraToshiyuki Kume
Dec 14, 2002·Annals of the Rheumatic Diseases·C MorganI N Bruce
Dec 19, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M AchiraT Kume
Jan 18, 2003·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Tarmo AnniloMichael Dean
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Oct 4, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Satohiro MasudaKen-ichi Inui
Aug 18, 2004·Current Opinion in Structural Biology·Kaspar P Locher
Mar 22, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Georgy HartmannMicheline Piquette-Miller
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Alison E AitkenEdward T Morgan
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Kenneth W Renton
Jan 5, 2007·Nature Clinical Practice. Rheumatology·Joost W van der HeijdenGerrit Jansen
Mar 10, 2007·Current Medicinal Chemistry·Junkang XuJian-Ting Zhang

❮ Previous
Next ❯

Citations

Jul 16, 2020·Phytotherapy Research : PTR·Haroon KhanSyed M M Shah
Mar 21, 2020·Frontiers in Oncology·Kianna Robinson, Venkataswarup Tiriveedhi
Aug 7, 2020·Inflammopharmacology·Jun Yu, Peng Zhou
Sep 18, 2020·Current Opinion in Pharmacology·Kai Xi ZhangVincent Kam Wai Wong
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kamal AbdolmohammadiMohammad Hossein Nicknam
Oct 25, 2021·International Immunopharmacology·Yi-Jin WuJian Zuo
Oct 31, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi-Jin WuWei Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
Teruo Murakami, Mikihisa Takano
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Wolfgang HagmannJ Matthias Löhr
General Physiology and Biophysics
J Kvackajová-KisuckáA Breier
© 2022 Meta ULC. All rights reserved